Revelstoke Capital Partners Announces Significant Growth Investment in MediQuant
Summary
As a result, demand for our solutions has grown significantly, and our enterprise-grade, HITRUST r2-certified offering continues to resonate with health system customers," said Jim Jacobs, CEO of MediQuant. MediQuant has built a differentiated platform that helps healthcare providers better manage data while achieving a tangible return on investment through reducing application spend, maintaining compliance with regulatory requirements, and increasing physician satisfaction," said Andrew Welch, Partner at Revelstoke. "We are excited to build on MediQuants leading platform and expand its scope of customers and capabilities," added Michael Temple, Vice President at Revelstoke.MediQuant was advised by Harris Williams and Ropes & Gray LLP. Revelstoke was advised by OM Partners, LLC and McGuireWoods LLP.About MediQuantFounded in 1999, MediQuant is a leader in enterprise active archiving and interoperability solutions for hospitals and health systems. With decades of experience successfully executing data conversions and archives across virtually all major EMR, EHR, ERP and Patient Accounting software vendors, MediQuant serves 250+ individual health systems, which represent more than 1,100 hospital and physician practice customers.
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
